Thumbnail Image
Publication

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice

Abstract
Executive Summary of the British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
Author
Schreiber, Karen
Frishman, Margreta
Russell, Mark D.
Dey, Mrinalini
Flint, Julia
Allen, Alexander
Crossley, Amy
Gayed, Mary
Hodson, Kenneth
Khamashta, Munther
Moore, Louise
Panchal, Sonia
Piper, Madeleine
Reid, Clare
Saxby, Katherine
Senvar, Naz
Tosounidou, Sofia
van de Venne, Maud
Warburton, Louise
Williams, David
Yee, Chee-Seng
Gordon, Caroline
Giles, Ian
BSR Standards, Audit and Guidelines Working Group
Citations
Altmetric:
Date
2023-04
Type
Guideline
Subject
Rheumatology, Obstetrics. Midwifery
Collections
SWFT Rheumatology
Research (Articles)
Research (Articles)
Show all metadata
Citation
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. Rheumatology (Oxford). 2023 Apr 3;62(4):1388-1397. doi: 10.1093/rheumatology/keac559.
Journal / Source Title
Rheumatology
DOI
10.1093/rheumatology/keac559
URI
http://hdl.handle.net/20.500.14200/820
PMID
36318970
Publisher
Oxford University Press
Publisher’s URL
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc10070061/
Publisher’s statement
Files
Thumbnail Image
Main article
Adobe PDF, 330.72 KB
Note / Copyright